SEARCH RESULT

Total Matching Records found : 300

Ending Indifference: A Law to Exile Hunger? by Harsh Mander

  Can we agree in this country on a floor of human dignity below which we will not allow any human being to fall? No child, woman or man in this land will sleep hungry. No person shall be forced to sleep under the open sky. No parent shall send their child out to work instead of to school. And no one shall die because they cannot afford the cost of...

More »

A Case for Reframing the Cash Transfer Debate in India by Sudha Narayanan

Cash transfers are now suggested by many as a silver bullet for addressing the problems that plague India’s anti-poverty programmes. This article argues instead for evidence-based policy and informed public debate to clarify the place, prospects and problems of cash transfers in India. By drawing on key empirical findings from academic and grey literature across the world an attempt is made to draw attention to three aspects of cash transfers...

More »

Rs 20/day is cutoff for urban poverty: Plan panel by Nitin Sethi

An urban Indian spending a penny more than Rs 578 a month – roughly Rs 20 a day – on all his basic needs cannot be termed poor and would not receive social benefits and subsidies given by the Centre to BPL citizens, the Planning Commission has said. The commission told the Supreme Court on Tuesday that a city dweller cannot be termed poor if his average monthly spends exceed Rs...

More »

All you wanted to know about Endosulfan (…but were afraid to ask!)

Endosulfan, the pesticide which is widely believed to be responsible for thousands of deaths, diseases and devastation, was able to save its own life largely because of India’s questionable efforts at global forums. The controversial pesticide has been in news for a long time because of its harmful effects on humans, wild life and the environment. Obviously the $100 million industry is going out of the way to defend the...

More »

MNC may need govt nod to buy local pharma firm by Khomba Singh

The government may approve acquisitions of local drugmakers by global firms on a case-by-case basis on certain conditions to ensure availability of medicines at affordable prices, despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years. Multinationals may have to move buyout proposals through the Foreign Investment Promotion Board (FIPB), allowing the government to understand the firm's rationale for buying a...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close